Skip to content

Peripheral Venous Stent System in the Treatment of Iliac Vein Stenosis or Occlusion

Safety and Efficacy of Peripheral Venous Stent System in the Treatment of Patients With Iliac Vein Stenosis or Occlusion: a Prospective, Multicentre, Randomized Controlled Clinical Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04812444
Enrollment
220
Registered
2021-03-23
Start date
2020-10-09
Completion date
2023-10-20
Last updated
2023-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iliac Vein Occlusion, Iliac Vein Stenosis

Keywords

Peripheral venous stent system, Iliac vein patency rate

Brief summary

Clinical study on safety and efficacy of Zylox peripheral venous stent system in the treatment of iliac vein stenosis or occlusion.

Detailed description

The purpose of this study was to evaluate the safety and efficacy of Zylox peripheral venous stent system in the treatment of iliac vein stenosis or occlusive lesions compare with conventional venous stent.

Interventions

DEVICEZylox Peripheral Venous Stent

Self-expanding stent implantation during the index procedure.

Self-expanding stent implantation during the index procedure.

Sponsors

Zhejiang Zylox Medical Device Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Aged from 18 to 75 years old, male or female * Subject's target lesions were stenosis and/or occlusion * CEAP≥C3 * Subjects were able to understand the purpose of the study, demonstrate full compliance with the program and sign informed consent

Exclusion criteria

* Pregnant woman or who's pregnancy test is positive * Lactation period woman or woman/man with fertility plan

Design outcomes

Primary

MeasureTime frameDescription
Target vascular patency rate at 12 months after operation12 monthsTarget vascular patency rate

Secondary

MeasureTime frameDescription
The incidence of major adverse events12 monthsRelated to death of clinical trials
Adverse EventPreoperative、Intraoperative、up to 1 month、3 month、6 month、12 month、2 years、3 years、5 yearsAdverse medical events,whether or not related to the medical device

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026